Gender differences in the regulation of blood pressure

被引:937
作者
Reckelhoff, JF
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA
关键词
sex characteristics; hypertension; angiotensin II; nitric oxide; oxidative stress;
D O I
10.1161/01.HYP.37.5.1199
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Men are at greater risk for cardiovascular and renal disease than are age-matched, premenopausal women. Recent studies using the technique of 24-hour ambulatory blood pressure monitoring have shown that blood pressure is higher in men than in women at similar ages. After menopause, however, blood pressure increases in women to levels even higher than in men. Hormone replacement therapy in most cases does not significantly reduce blood pressure in postmenopausal women, suggesting that the loss of estrogens may not be the only component involved in the higher blood pressure in women after menopause. In contrast, androgens may decrease only slightly, if at all, in postmenopausal women. In this review the possible mechanisms by which androgens may increase blood pressure are discussed. Findings in animal studies show that there is a blunting of the pressure-natriuresis relationship in male spontaneously hypertensive rats and in ovariectomized female spontaneously hypertensive rats treated chronically with testosterone. The key factor in controlling the pressure-natriuresis relationship is the renin-angiotensin system (RAS). The possibility that androgens increase blood pressure via the RAS is explored, and the possibility that the RAS also promotes oxidative stress leading to production of vasoconstrictor substances and reduction in nitric oxide availability is proposed.
引用
收藏
页码:1199 / 1208
页数:10
相关论文
共 92 条
  • [51] Transdermal oestrogen reduces daytime blood pressure in hypertensive women
    Manhem, K
    Ahlm, H
    Milsom, I
    Svensson, A
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1998, 12 (05) : 323 - 327
  • [52] Long-term effects of finasteride on prostate tissue composition
    Marks, LS
    Partin, AW
    Dorey, FJ
    Gormley, GJ
    Epstein, JI
    Garris, JB
    Macairan, ML
    Shery, ED
    Santos, PB
    Stoner, E
    deKernion, JB
    [J]. UROLOGY, 1999, 53 (03) : 574 - 580
  • [53] GONADECTOMY-INDUCED REDUCTION OF BLOOD-PRESSURE IN ADULT SPONTANEOUSLY HYPERTENSIVE RATS
    MASUBUCHI, Y
    KUMAI, T
    UEMATSU, A
    KOMORIYAMA, K
    HIRAI, M
    [J]. ACTA ENDOCRINOLOGICA, 1982, 101 (01): : 154 - 160
  • [54] TESTOSTERONE INCREASES THROMBOXANE-A2 RECEPTORS IN CULTURED RAT AORTIC SMOOTH-MUSCLE CELLS
    MASUDA, A
    MATHUR, R
    HALUSHKA, PV
    [J]. CIRCULATION RESEARCH, 1991, 69 (03) : 638 - 643
  • [55] MATTSSON LA, 1984, FERTIL STERIL, V42, P579
  • [56] Impact of gender on the renal response to angiotensin II
    Miller, JA
    Anacta, LA
    Cattran, DC
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (01) : 278 - 285
  • [57] EFFECTS OF ESTROGEN OR ESTROGEN/PROGESTIN REGIMENS ON HEART-DISEASE RISK-FACTORS IN POSTMENOPAUSAL WOMEN - THE POSTMENOPAUSAL ESTROGEN/PROGESTIN INTERVENTIONS (PEPI) TRIAL
    MILLER, VT
    LAROSA, J
    BARNABEI, V
    KESSLER, C
    LEVIN, G
    SMITHROTH, A
    GRIFFIN, M
    STOY, DB
    BUSH, T
    ZACUR, H
    FOSTER, D
    ANDERSON, J
    MCKENZIE, A
    MILLER, S
    WOOD, PD
    STEFANICK, ML
    MARCUS, R
    AKANA, A
    HEINRICHS, L
    KIRCHNER, C
    OHANLAN, K
    RUYLE, M
    SHEEHAN, M
    JUDD, HL
    GREENDALE, G
    BAYALOS, R
    LOZANO, K
    KAWAKAMI, K
    BARRETTCONNOR, E
    LANGER, R
    KRITZSILVERSTEIN, D
    CARRIONPETERSEN, ML
    CAVERO, C
    SCHROTT, HG
    JOHNSON, SR
    FEDDERSEN, DA
    KRUTZFELDT, DL
    BENDA, JA
    PAUERSTEIN, C
    TRABAL, J
    SCHENKEN, R
    STERN, MP
    RODRIGUEZSIFUENTES, M
    EASTON, C
    WELLS, HB
    ESPELAND, M
    HOWARD, G
    BYINGTON, R
    LEGAULT, C
    SHUMAKER, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (03): : 199 - 208
  • [58] A SERIES OF PROSTAGLANDIN-F2-LIKE COMPOUNDS ARE PRODUCED INVIVO IN HUMANS BY A NONCYCLOOXYGENASE, FREE RADICAL-CATALYZED MECHANISM
    MORROW, JD
    HILL, KE
    BURK, RF
    NAMMOUR, TM
    BADR, KF
    ROBERTS, LJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) : 9383 - 9387
  • [59] The isoprostanes: Unique bioactive products of lipid peroxidation
    Morrow, JD
    Roberts, LJ
    [J]. PROGRESS IN LIPID RESEARCH, 1997, 36 (01) : 1 - 21
  • [60] Estrogen modulates AT1 receptor gene expression in vitro and in vivo
    Nickenig, G
    Bäumer, AT
    Grohè, C
    Kahlert, S
    Strehlow, K
    Rosenkranz, S
    Stäblein, A
    Beckers, F
    Smits, JFM
    Daemen, MJAP
    Vetter, H
    Böhm, M
    [J]. CIRCULATION, 1998, 97 (22) : 2197 - 2201